These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3181045

  • 1. [Hypercholesterolemia and the diagnosis and management of hyper- lipidemia in adults. Recommendations of the working groups of the Finnish Society of Internal Medicine and the Finnish Cardiology Society].
    Duodecim; 1988; 104(18):1425-38. PubMed ID: 3181045
    [No Abstract] [Full Text] [Related]

  • 2. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
    Fodor JG, Frohlich JJ, Genest JJ, McPherson PR.
    CMAJ; 2000 May 16; 162(10):1441-7. PubMed ID: 10834048
    [No Abstract] [Full Text] [Related]

  • 3. Diagnosis and management of hyperlipidemia.
    Palumbo PJ.
    Compr Ther; 1978 Oct 16; 4(10):33-9. PubMed ID: 359229
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN, Poliakova ED, Olfer'ev AM, Perova NV.
    Biull Eksp Biol Med; 1998 May 16; 125(5):569-73. PubMed ID: 9644562
    [No Abstract] [Full Text] [Related]

  • 5. [Diagnosis and treatment of hypercholesterolemia and other and hyperlipidemias in the year 1992. Finnish Associations of Internists, Cardiologists, Heart Diseases, Community Physicians, and the Committee of Industrial Medicine].
    Duodecim; 1993 May 16; 109(6):481-501. PubMed ID: 8062717
    [No Abstract] [Full Text] [Related]

  • 6. Drug therapy for hyperlipidemia.
    Franklin FA, Margolis S.
    Cardiovasc Clin; 1984 May 16; 14(3):265-84. PubMed ID: 6722855
    [No Abstract] [Full Text] [Related]

  • 7. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada.
    Frohlich J, Fodor G, McPherson R, Genest J, Langner N.
    Can J Cardiol; 1998 Apr 16; 14 Suppl A():17A-21A. PubMed ID: 9594929
    [Abstract] [Full Text] [Related]

  • 8. Recommendations for the treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis of the American Heart Association.
    Arteriosclerosis; 1984 Apr 16; 4(4):443A-468A. PubMed ID: 6466199
    [No Abstract] [Full Text] [Related]

  • 9. The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain.
    Tapounet R, Marti Ragué I.
    Drugs Exp Clin Res; 1987 Apr 16; 13(7):447-50. PubMed ID: 3652931
    [Abstract] [Full Text] [Related]

  • 10. Hyperlipoproteinemias in the prematurely aged. Theories of pathogenesis, diagnosis, classification, and treatment.
    Herrmann GR.
    Geriatrics; 1970 Apr 16; 25(4):103-14. PubMed ID: 5443794
    [No Abstract] [Full Text] [Related]

  • 11. [Drug therapy of dyslipidemias].
    Fonda M, Cattin L, Guarnieri G.
    Recenti Prog Med; 2000 Apr 16; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract] [Full Text] [Related]

  • 12. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
    Kurmukov AG, Aĭzikov MI, Rasulova SA, Makhmudov OKh.
    Farmakol Toksikol; 1986 Apr 16; 49(6):54-7. PubMed ID: 3817147
    [Abstract] [Full Text] [Related]

  • 13. [What should be the role of antilipemic agents in the control of hypercholesterolemia in elderly persons?].
    Champoux N, Latour J.
    Union Med Can; 1994 Feb 16; 123(2):91-4. PubMed ID: 8203037
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical trial of tibric acid, a new hypolipidemic agent].
    Noseda G, Sirtori CR.
    Schweiz Med Wochenschr; 1974 Dec 21; 104(51):1917-22. PubMed ID: 4438990
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H, Jaillard J.
    Lille Med; 1974 Apr 21; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract] [Full Text] [Related]

  • 16. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A, Aguilar-Salinas CA.
    Gac Med Mex; 1998 Apr 21; 134(2):253-6. PubMed ID: 9619005
    [No Abstract] [Full Text] [Related]

  • 17. [High cholesterol levels are discriminated by new therapeutic recommendations].
    Olsson AG.
    Lakartidningen; 2000 Apr 19; 97(16):1995-6. PubMed ID: 10826361
    [No Abstract] [Full Text] [Related]

  • 18. [Classification of hyperlipoproteinemias].
    Zabel R.
    Dermatol Monatsschr; 1974 Feb 19; 160(2):134-50. PubMed ID: 4369507
    [No Abstract] [Full Text] [Related]

  • 19. Effects of bezafibrate and gemfibrozil on serum lipoproteins in primary hypercholesterolemia.
    Weisweiler P.
    Arzneimittelforschung; 1988 Jul 19; 38(7):925-7. PubMed ID: 3207437
    [Abstract] [Full Text] [Related]

  • 20. [Assessment of hypolipemic action of the preparation olbetam in people with primary hypercholesterolemia].
    Miturzyńska-Stryjecka H, Widomska-Czekajska T, Bielak G, Grossmann G.
    Wiad Lek; 1994 Aug 19; 47(15-16):566-9. PubMed ID: 7716950
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.